Drugs / rDEN1delta30
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00473135 | May 2007 → Jan 2010 | dengue disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT00458120 | Mar 2007 → Aug 2008 | Dengue hemorrhagic fever | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT00089908 | Sep 2004 → Nov 2005 | dengue disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rDEN1delta30 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00473135 ↗ |
| Modality | Vaccine | “Live attenuated 10\^3 dose of rDEN1delta30 vaccine.” NCT00458120 ↗ |
| Route | Subcutaneous | “One subcutaneous vaccination with rDEN1delta30 vaccine” NCT00089908 ↗ |